2.1 Training Requirements & Medical Surveillance
Key Takeaways
- USP <800> requires initial training before independent HD handling, plus competency assessment of demonstrated technique (garbing, CSTD use, spill response) and at least annual retraining
- The medical surveillance program includes pre-placement, periodic (e.g., annual), post-exposure/incident, and exit exams for anyone who handles hazardous drugs
- Employees who are pregnant, trying to conceive, or breastfeeding must receive reproductive-health counseling, but stepping away from HD duties is the employee's voluntary choice, not a mandatory rule
- Training content must be built around the facility's own hazardous drug list, SOPs, PPE, and engineering controls, not a generic national course
- Competency assessment has two required parts: didactic knowledge and hands-on demonstrated technique
Training Requirements & Medical Surveillance
Quick Answer: USP <800> requires two parallel administrative safeguards for anyone who handles hazardous drugs (HDs): documented initial and periodic training with competency assessment, and a medical surveillance program covering pre-placement, periodic, post-exposure, and exit exams, plus voluntary reproductive-health counseling. Both are Administrative-domain (22%) content and are heavily tested because they generate the paper trail inspectors check first.
Why This Matters
A pharmacy can own every engineering control USP <800> requires — a certified CACI, a negative-pressure C-SEC room, closed system transfer devices — and still fail an inspection if it cannot prove that the people working in that space were trained to use those controls and are being medically monitored for the exposure risk. Training and medical surveillance are the human-factor half of the HD safety program, and PTCB tests them as concretely as it tests engineering specifications.
Training Requirements
USP <800> requires personnel who handle HDs to complete training before they are permitted to work independently, and then to be reassessed on a recurring basis.
| Training Stage | Timing | What Must Be Demonstrated |
|---|---|---|
| Initial training | Before independent HD handling begins | Didactic knowledge of the facility's HD list, SOPs, and hazard classes |
| Competency assessment | Before independent handling; repeated periodically | Demonstrated technique: garbing/gloving order, use of a CSTD, spill response, proper cleaning/deactivation |
| Periodic retraining | At least annually | Re-assessment of both didactic knowledge and hands-on technique |
Training content is not generic — it must be built around the facility's own list of hazardous drugs, its written SOPs, the specific PPE it stocks, the engineering controls it has installed, and its spill-response plan. A national training video that never mentions the pharmacy's actual CSTD model or its actual spill kit location does not satisfy the standard.
Training has two halves that both have to be checked off: didactic (classroom/written knowledge — hazard classes, SOP content, why controls exist) and demonstrated technique (hands-on — correctly donning/doffing PPE in sequence, operating the CSTD, executing the four-step spill response). A technician who can recite the SOP but has never been observed performing a spill cleanup has not completed competency assessment.
Exam Tip: "Initial training only" is a trap answer. USP <800> requires at least annual reassessment for as long as the person continues to handle HDs — training is not a one-time credential.
The Medical Surveillance Program
USP <800> requires a medical surveillance program for personnel who handle HDs, administered by (or coordinated through) the employer's occupational health provider.
| Exam Type | When It Happens | Purpose |
|---|---|---|
| Pre-placement exam | Before the employee begins HD-handling duties | Establish a baseline health status before exposure risk begins |
| Periodic exam | Ongoing, e.g., annually | Monitor for changes that could indicate cumulative exposure effects |
| Post-exposure/incident exam | After a suspected significant exposure or spill | Evaluate and document any acute health effects |
| Exit exam | When the employee stops handling HDs | Establish a closing health record for comparison |
Reproductive Health Considerations
Because many hazardous drugs carry documented teratogenic or reproductive-toxicity risk, the medical surveillance program must include reproductive-health monitoring and counseling for any employee who is pregnant, trying to conceive, or breastfeeding. This is a critical nuance PTCB likes to test: the requirement is to offer counseling and the option to decline HD-handling duties without penalty — it is not a rule that automatically removes or reassigns a pregnant employee. The decision belongs to the employee after being informed of the risks.
Scenario
A compounding technician is transferred from a general dispensing role into the sterile HD compounding room. Before she can compound independently, she must complete initial didactic training on the facility's HD list and SOPs, pass a demonstrated-technique competency assessment covering garbing, CSTD use, and spill response, and undergo a pre-placement medical exam. Two years later, during her annual competency reassessment, she informs her supervisor she is trying to conceive. The correct response is to provide reproductive-health counseling and offer her the option — not the requirement — to step away from HD duties.
Key Takeaways
- Training has two mandatory parts: didactic knowledge and demonstrated technique
- Competency assessment happens before independent handling and at least annually thereafter
- Training content must reflect the facility's actual HD list, SOPs, PPE, and controls
- Medical surveillance = pre-placement, periodic, post-exposure/incident, and exit exams
- Reproductive-health counseling is required, but stepping away from HD duties is the employee's voluntary choice
Which of the following is NOT a required component of the USP <800> medical surveillance program?
A pharmacy technician is transferred into the hazardous drug compounding area. Per USP <800>, which of the following must occur before she is permitted to compound HDs independently?